Newsletter-1118-02
If you are having trouble viewing this e-mail, please click here.
 
 
 
 
Issue #1118
 
Top Articles
 
 
Muscling in on Malignant Hyperthermia
 
Skinned muscle fibers from needle biopsies could be used to identify patients who are susceptible to malignant hyperthermia.
 
 
 
 
Peer-to-Peer, Featuring Fátima Carneiro
 
The 2018 Power List winner talks education, recruitment, and the lessons she has learned throughout her successful career.
 
 
 
 
Biochip Breakthrough
 
A portable biochip can rapidly and simultaneously detect microbes to identify mutations, facilitating the selection of the most effective treatment.
 
 
 
 
 
What’s the best piece of career advice you’ve ever been given? We want to hear it – and share it! Tell us about it on Twitter (@pathologistmag) with the #PathAdvice hashtag or via email and you may be part of an upcoming article…
 
 
Get more from The Pathologist. Connect and interact online through Twitter (@pathologistmag), Facebook, LinkedIn, Google Plus, Instagram, or even YouTube!
 
 
 
 
 
Webinars
 
 
Principles and considerations for Tumor Mutational Burden (TMB) testing
 
Register your place for the illumina webinar on December 5, 2018 at 17.00 CET on Principles and Considerations for Tumor Mutational Burden (TMB).
 
 
 
Effective Pathology Collaboration in an Increasingly Digital World
 
Join Editor Michael Schubert, along with representatives from Proscia and Hamamatsu, in this educational webinar that explains the growing need for pathologists to collaborate remotely. Typically associated with academic medical centers and other educational institutions, remote collaboration is becoming increasingly critical in all types of pathology lab setups.

11 December 2018, 11 am EST / 4 pm GMT
 
 
 
 
Product Profiles
 
 
We listened. We learned. Now we lead.
 
EKF Diagnostics has developed Quo-Lab, a semi-automated HbA1c analyser, in conjunction with industry experts to deliver a product that meets the requirements of NGSP certification and CAP EQA criteria.
 
 
 
Announcing TruSight™ Oncology 500 for tumor mutational burden assessment
 
TruSight™ Oncology 500 (TSO500), a comprehensive gene panel from Illumina, enabling research laboratories to evaluate both DNA and RNA biomarkers with content aligned to key clinical guidelines for assessment of TMB (tumor mutational burden) and MSI (microsatellite instability).
 
 
 
 
Special Promotions
 
 
The future is now for NGS and pathology. Are you ready?
 
Join Agilent as we combine our Genomics Solutions with Dako Pathology on the new frontier of cancer pathology. Learn best wet-lab practices, basics of data analysis, and the impact of our clinical-grade draft reports on precision medicine
 
 
 
Automated, Label-Free Chemical Imaging of Colorectal Cancer
 
Researchers at the Ruhr University Bochum took a major step towards the clinical translation of label-free infrared chemical imaging. In a 110 patient feasibility study, the researchers identified new infrared biomarkers for colorectal cancer with a high degree of specificity and sensitivity.
 
 
 
 
Events
 
 
Upcoming Events
 
Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the laboratory medicine industry – so why not take a look at our list of upcoming events?